Herpes Zoste Drug Market
1 Study Coverage
1.1 Herpes Zoste Drug Product Introduction
1.2 Market by Type
1.2.1 Global Herpes Zoste Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Acyclovir
1.2.3 Amenamevir
1.2.4 FV-100
1.2.5 GLS-5100
1.2.6 GSK-1437173A
1.2.7 NAL-3221
1.2.8 Others
1.3 Market by Application
1.3.1 Global Herpes Zoste Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Herpes Zoste Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Herpes Zoste Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Herpes Zoste Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Herpes Zoste Drug Sales by Region
2.4.1 Global Herpes Zoste Drug Sales by Region (2017-2022)
2.4.2 Global Sales Herpes Zoste Drug by Region (2023-2028)
2.5 Global Herpes Zoste Drug Revenue by Region
2.5.1 Global Herpes Zoste Drug Revenue by Region (2017-2022)
2.5.2 Global Herpes Zoste Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Herpes Zoste Drug Sales by Manufacturers
3.1.1 Global Top Herpes Zoste Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Herpes Zoste Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Herpes Zoste Drug in 2021
3.2 Global Herpes Zoste Drug Revenue by Manufacturers
3.2.1 Global Herpes Zoste Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Herpes Zoste Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Herpes Zoste Drug Revenue in 2021
3.3 Global Herpes Zoste Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Herpes Zoste Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Herpes Zoste Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Herpes Zoste Drug Sales by Type
4.1.1 Global Herpes Zoste Drug Historical Sales by Type (2017-2022)
4.1.2 Global Herpes Zoste Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Herpes Zoste Drug Sales Market Share by Type (2017-2028)
4.2 Global Herpes Zoste Drug Revenue by Type
4.2.1 Global Herpes Zoste Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Herpes Zoste Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Herpes Zoste Drug Revenue Market Share by Type (2017-2028)
4.3 Global Herpes Zoste Drug Price by Type
4.3.1 Global Herpes Zoste Drug Price by Type (2017-2022)
4.3.2 Global Herpes Zoste Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Herpes Zoste Drug Sales by Application
5.1.1 Global Herpes Zoste Drug Historical Sales by Application (2017-2022)
5.1.2 Global Herpes Zoste Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Herpes Zoste Drug Sales Market Share by Application (2017-2028)
5.2 Global Herpes Zoste Drug Revenue by Application
5.2.1 Global Herpes Zoste Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Herpes Zoste Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Herpes Zoste Drug Revenue Market Share by Application (2017-2028)
5.3 Global Herpes Zoste Drug Price by Application
5.3.1 Global Herpes Zoste Drug Price by Application (2017-2022)
5.3.2 Global Herpes Zoste Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Herpes Zoste Drug Market Size by Type
6.1.1 North America Herpes Zoste Drug Sales by Type (2017-2028)
6.1.2 North America Herpes Zoste Drug Revenue by Type (2017-2028)
6.2 North America Herpes Zoste Drug Market Size by Application
6.2.1 North America Herpes Zoste Drug Sales by Application (2017-2028)
6.2.2 North America Herpes Zoste Drug Revenue by Application (2017-2028)
6.3 North America Herpes Zoste Drug Market Size by Country
6.3.1 North America Herpes Zoste Drug Sales by Country (2017-2028)
6.3.2 North America Herpes Zoste Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Herpes Zoste Drug Market Size by Type
7.1.1 Europe Herpes Zoste Drug Sales by Type (2017-2028)
7.1.2 Europe Herpes Zoste Drug Revenue by Type (2017-2028)
7.2 Europe Herpes Zoste Drug Market Size by Application
7.2.1 Europe Herpes Zoste Drug Sales by Application (2017-2028)
7.2.2 Europe Herpes Zoste Drug Revenue by Application (2017-2028)
7.3 Europe Herpes Zoste Drug Market Size by Country
7.3.1 Europe Herpes Zoste Drug Sales by Country (2017-2028)
7.3.2 Europe Herpes Zoste Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Herpes Zoste Drug Market Size by Type
8.1.1 Asia Pacific Herpes Zoste Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Herpes Zoste Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Herpes Zoste Drug Market Size by Application
8.2.1 Asia Pacific Herpes Zoste Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Herpes Zoste Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Herpes Zoste Drug Market Size by Region
8.3.1 Asia Pacific Herpes Zoste Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Herpes Zoste Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Herpes Zoste Drug Market Size by Type
9.1.1 Latin America Herpes Zoste Drug Sales by Type (2017-2028)
9.1.2 Latin America Herpes Zoste Drug Revenue by Type (2017-2028)
9.2 Latin America Herpes Zoste Drug Market Size by Application
9.2.1 Latin America Herpes Zoste Drug Sales by Application (2017-2028)
9.2.2 Latin America Herpes Zoste Drug Revenue by Application (2017-2028)
9.3 Latin America Herpes Zoste Drug Market Size by Country
9.3.1 Latin America Herpes Zoste Drug Sales by Country (2017-2028)
9.3.2 Latin America Herpes Zoste Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Herpes Zoste Drug Market Size by Type
10.1.1 Middle East and Africa Herpes Zoste Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Herpes Zoste Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Herpes Zoste Drug Market Size by Application
10.2.1 Middle East and Africa Herpes Zoste Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Herpes Zoste Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Herpes Zoste Drug Market Size by Country
10.3.1 Middle East and Africa Herpes Zoste Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Herpes Zoste Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Overview
11.1.3 Astellas Pharma Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Astellas Pharma Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Astellas Pharma Inc. Recent Developments
11.2 Beijing Minhai Biotechnology Co., Ltd
11.2.1 Beijing Minhai Biotechnology Co., Ltd Corporation Information
11.2.2 Beijing Minhai Biotechnology Co., Ltd Overview
11.2.3 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
11.3 ContraVir Pharmaceuticals, Inc.
11.3.1 ContraVir Pharmaceuticals, Inc. Corporation Information
11.3.2 ContraVir Pharmaceuticals, Inc. Overview
11.3.3 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ContraVir Pharmaceuticals, Inc. Recent Developments
11.4 Epiphany Biosciences, Inc.
11.4.1 Epiphany Biosciences, Inc. Corporation Information
11.4.2 Epiphany Biosciences, Inc. Overview
11.4.3 Epiphany Biosciences, Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Epiphany Biosciences, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Epiphany Biosciences, Inc. Recent Developments
11.5 Foamix Pharmaceuticals Ltd.
11.5.1 Foamix Pharmaceuticals Ltd. Corporation Information
11.5.2 Foamix Pharmaceuticals Ltd. Overview
11.5.3 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Foamix Pharmaceuticals Ltd. Recent Developments
11.6 GeneOne Life Science, Inc.
11.6.1 GeneOne Life Science, Inc. Corporation Information
11.6.2 GeneOne Life Science, Inc. Overview
11.6.3 GeneOne Life Science, Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GeneOne Life Science, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GeneOne Life Science, Inc. Recent Developments
11.7 GlaxoSmithKline Plc
11.7.1 GlaxoSmithKline Plc Corporation Information
11.7.2 GlaxoSmithKline Plc Overview
11.7.3 GlaxoSmithKline Plc Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GlaxoSmithKline Plc Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GlaxoSmithKline Plc Recent Developments
11.8 Merck & Co., Inc.
11.8.1 Merck & Co., Inc. Corporation Information
11.8.2 Merck & Co., Inc. Overview
11.8.3 Merck & Co., Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck & Co., Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck & Co., Inc. Recent Developments
11.9 NAL Pharmaceuticals Ltd.
11.9.1 NAL Pharmaceuticals Ltd. Corporation Information
11.9.2 NAL Pharmaceuticals Ltd. Overview
11.9.3 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 NAL Pharmaceuticals Ltd. Recent Developments
11.10 ReceptoPharm, Inc.
11.10.1 ReceptoPharm, Inc. Corporation Information
11.10.2 ReceptoPharm, Inc. Overview
11.10.3 ReceptoPharm, Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 ReceptoPharm, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 ReceptoPharm, Inc. Recent Developments
11.11 TSRL, Inc.
11.11.1 TSRL, Inc. Corporation Information
11.11.2 TSRL, Inc. Overview
11.11.3 TSRL, Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 TSRL, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 TSRL, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Herpes Zoste Drug Industry Chain Analysis
12.2 Herpes Zoste Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Herpes Zoste Drug Production Mode & Process
12.4 Herpes Zoste Drug Sales and Marketing
12.4.1 Herpes Zoste Drug Sales Channels
12.4.2 Herpes Zoste Drug Distributors
12.5 Herpes Zoste Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Herpes Zoste Drug Industry Trends
13.2 Herpes Zoste Drug Market Drivers
13.3 Herpes Zoste Drug Market Challenges
13.4 Herpes Zoste Drug Market Restraints
14 Key Findings in The Global Herpes Zoste Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Herpes Zoste Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Acyclovir
Table 3. Major Manufacturers of Amenamevir
Table 4. Major Manufacturers of FV-100
Table 5. Major Manufacturers of GLS-5100
Table 6. Major Manufacturers of GSK-1437173A
Table 7. Major Manufacturers of NAL-3221
Table 8. Major Manufacturers of Others
Table 9. Global Herpes Zoste Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Herpes Zoste Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Herpes Zoste Drug Sales by Region (2017-2022) & (K Pcs)
Table 12. Global Herpes Zoste Drug Sales Market Share by Region (2017-2022)
Table 13. Global Herpes Zoste Drug Sales by Region (2023-2028) & (K Pcs)
Table 14. Global Herpes Zoste Drug Sales Market Share by Region (2023-2028)
Table 15. Global Herpes Zoste Drug Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Herpes Zoste Drug Revenue Market Share by Region (2017-2022)
Table 17. Global Herpes Zoste Drug Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Herpes Zoste Drug Revenue Market Share by Region (2023-2028)
Table 19. Global Herpes Zoste Drug Sales by Manufacturers (2017-2022) & (K Pcs)
Table 20. Global Herpes Zoste Drug Sales Share by Manufacturers (2017-2022)
Table 21. Global Herpes Zoste Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Herpes Zoste Drug Revenue Share by Manufacturers (2017-2022)
Table 23. Herpes Zoste Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 24. Global Herpes Zoste Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Herpes Zoste Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Zoste Drug as of 2021)
Table 26. Herpes Zoste Drug Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Herpes Zoste Drug Product Offered
Table 28. Date of Manufacturers Enter into Herpes Zoste Drug Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Herpes Zoste Drug Sales by Type (2017-2022) & (K Pcs)
Table 31. Global Herpes Zoste Drug Sales by Type (2023-2028) & (K Pcs)
Table 32. Global Herpes Zoste Drug Sales Share by Type (2017-2022)
Table 33. Global Herpes Zoste Drug Sales Share by Type (2023-2028)
Table 34. Global Herpes Zoste Drug Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Herpes Zoste Drug Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Herpes Zoste Drug Revenue Share by Type (2017-2022)
Table 37. Global Herpes Zoste Drug Revenue Share by Type (2023-2028)
Table 38. Herpes Zoste Drug Price by Type (2017-2022) & (USD/Pcs)
Table 39. Global Herpes Zoste Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 40. Global Herpes Zoste Drug Sales by Application (2017-2022) & (K Pcs)
Table 41. Global Herpes Zoste Drug Sales by Application (2023-2028) & (K Pcs)
Table 42. Global Herpes Zoste Drug Sales Share by Application (2017-2022)
Table 43. Global Herpes Zoste Drug Sales Share by Application (2023-2028)
Table 44. Global Herpes Zoste Drug Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Herpes Zoste Drug Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Herpes Zoste Drug Revenue Share by Application (2017-2022)
Table 47. Global Herpes Zoste Drug Revenue Share by Application (2023-2028)
Table 48. Herpes Zoste Drug Price by Application (2017-2022) & (USD/Pcs)
Table 49. Global Herpes Zoste Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 50. North America Herpes Zoste Drug Sales by Type (2017-2022) & (K Pcs)
Table 51. North America Herpes Zoste Drug Sales by Type (2023-2028) & (K Pcs)
Table 52. North America Herpes Zoste Drug Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Herpes Zoste Drug Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Herpes Zoste Drug Sales by Application (2017-2022) & (K Pcs)
Table 55. North America Herpes Zoste Drug Sales by Application (2023-2028) & (K Pcs)
Table 56. North America Herpes Zoste Drug Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Herpes Zoste Drug Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Herpes Zoste Drug Sales by Country (2017-2022) & (K Pcs)
Table 59. North America Herpes Zoste Drug Sales by Country (2023-2028) & (K Pcs)
Table 60. North America Herpes Zoste Drug Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Herpes Zoste Drug Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Herpes Zoste Drug Sales by Type (2017-2022) & (K Pcs)
Table 63. Europe Herpes Zoste Drug Sales by Type (2023-2028) & (K Pcs)
Table 64. Europe Herpes Zoste Drug Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Herpes Zoste Drug Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Herpes Zoste Drug Sales by Application (2017-2022) & (K Pcs)
Table 67. Europe Herpes Zoste Drug Sales by Application (2023-2028) & (K Pcs)
Table 68. Europe Herpes Zoste Drug Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Herpes Zoste Drug Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Herpes Zoste Drug Sales by Country (2017-2022) & (K Pcs)
Table 71. Europe Herpes Zoste Drug Sales by Country (2023-2028) & (K Pcs)
Table 72. Europe Herpes Zoste Drug Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Herpes Zoste Drug Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Herpes Zoste Drug Sales by Type (2017-2022) & (K Pcs)
Table 75. Asia Pacific Herpes Zoste Drug Sales by Type (2023-2028) & (K Pcs)
Table 76. Asia Pacific Herpes Zoste Drug Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Herpes Zoste Drug Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Herpes Zoste Drug Sales by Application (2017-2022) & (K Pcs)
Table 79. Asia Pacific Herpes Zoste Drug Sales by Application (2023-2028) & (K Pcs)
Table 80. Asia Pacific Herpes Zoste Drug Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Herpes Zoste Drug Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Herpes Zoste Drug Sales by Region (2017-2022) & (K Pcs)
Table 83. Asia Pacific Herpes Zoste Drug Sales by Region (2023-2028) & (K Pcs)
Table 84. Asia Pacific Herpes Zoste Drug Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Herpes Zoste Drug Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Herpes Zoste Drug Sales by Type (2017-2022) & (K Pcs)
Table 87. Latin America Herpes Zoste Drug Sales by Type (2023-2028) & (K Pcs)
Table 88. Latin America Herpes Zoste Drug Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Herpes Zoste Drug Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Herpes Zoste Drug Sales by Application (2017-2022) & (K Pcs)
Table 91. Latin America Herpes Zoste Drug Sales by Application (2023-2028) & (K Pcs)
Table 92. Latin America Herpes Zoste Drug Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Herpes Zoste Drug Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Herpes Zoste Drug Sales by Country (2017-2022) & (K Pcs)
Table 95. Latin America Herpes Zoste Drug Sales by Country (2023-2028) & (K Pcs)
Table 96. Latin America Herpes Zoste Drug Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Herpes Zoste Drug Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Herpes Zoste Drug Sales by Type (2017-2022) & (K Pcs)
Table 99. Middle East and Africa Herpes Zoste Drug Sales by Type (2023-2028) & (K Pcs)
Table 100. Middle East and Africa Herpes Zoste Drug Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Herpes Zoste Drug Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Herpes Zoste Drug Sales by Application (2017-2022) & (K Pcs)
Table 103. Middle East and Africa Herpes Zoste Drug Sales by Application (2023-2028) & (K Pcs)
Table 104. Middle East and Africa Herpes Zoste Drug Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Herpes Zoste Drug Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Herpes Zoste Drug Sales by Country (2017-2022) & (K Pcs)
Table 107. Middle East and Africa Herpes Zoste Drug Sales by Country (2023-2028) & (K Pcs)
Table 108. Middle East and Africa Herpes Zoste Drug Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Herpes Zoste Drug Revenue by Country (2023-2028) & (US$ Million)
Table 110. Astellas Pharma Inc. Corporation Information
Table 111. Astellas Pharma Inc. Description and Major Businesses
Table 112. Astellas Pharma Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 113. Astellas Pharma Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Astellas Pharma Inc. Recent Developments
Table 115. Beijing Minhai Biotechnology Co., Ltd Corporation Information
Table 116. Beijing Minhai Biotechnology Co., Ltd Description and Major Businesses
Table 117. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 118. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Beijing Minhai Biotechnology Co., Ltd Recent Developments
Table 120. ContraVir Pharmaceuticals, Inc. Corporation Information
Table 121. ContraVir Pharmaceuticals, Inc. Description and Major Businesses
Table 122. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 123. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. ContraVir Pharmaceuticals, Inc. Recent Developments
Table 125. Epiphany Biosciences, Inc. Corporation Information
Table 126. Epiphany Biosciences, Inc. Description and Major Businesses
Table 127. Epiphany Biosciences, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 128. Epiphany Biosciences, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Epiphany Biosciences, Inc. Recent Developments
Table 130. Foamix Pharmaceuticals Ltd. Corporation Information
Table 131. Foamix Pharmaceuticals Ltd. Description and Major Businesses
Table 132. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 133. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Foamix Pharmaceuticals Ltd. Recent Developments
Table 135. GeneOne Life Science, Inc. Corporation Information
Table 136. GeneOne Life Science, Inc. Description and Major Businesses
Table 137. GeneOne Life Science, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 138. GeneOne Life Science, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. GeneOne Life Science, Inc. Recent Developments
Table 140. GlaxoSmithKline Plc Corporation Information
Table 141. GlaxoSmithKline Plc Description and Major Businesses
Table 142. GlaxoSmithKline Plc Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 143. GlaxoSmithKline Plc Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. GlaxoSmithKline Plc Recent Developments
Table 145. Merck & Co., Inc. Corporation Information
Table 146. Merck & Co., Inc. Description and Major Businesses
Table 147. Merck & Co., Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 148. Merck & Co., Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Merck & Co., Inc. Recent Developments
Table 150. NAL Pharmaceuticals Ltd. Corporation Information
Table 151. NAL Pharmaceuticals Ltd. Description and Major Businesses
Table 152. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 153. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. NAL Pharmaceuticals Ltd. Recent Developments
Table 155. ReceptoPharm, Inc. Corporation Information
Table 156. ReceptoPharm, Inc. Description and Major Businesses
Table 157. ReceptoPharm, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 158. ReceptoPharm, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. ReceptoPharm, Inc. Recent Developments
Table 160. TSRL, Inc. Corporation Information
Table 161. TSRL, Inc. Description and Major Businesses
Table 162. TSRL, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 163. TSRL, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. TSRL, Inc. Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Herpes Zoste Drug Distributors List
Table 168. Herpes Zoste Drug Customers List
Table 169. Herpes Zoste Drug Market Trends
Table 170. Herpes Zoste Drug Market Drivers
Table 171. Herpes Zoste Drug Market Challenges
Table 172. Herpes Zoste Drug Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Herpes Zoste Drug Product Picture
Figure 3. Global Herpes Zoste Drug Market Share by Type in 2021 & 2028
Figure 3. Acyclovir Product Picture
Figure 4. Amenamevir Product Picture
Figure 5. FV-100 Product Picture
Figure 6. GLS-5100 Product Picture
Figure 7. GSK-1437173A Product Picture
Figure 8. NAL-3221 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Herpes Zoste Drug Market Share by Application in 2021 & 2028
Figure 11. Clinic
Figure 12. Hospital
Figure 13. Others
Figure 14. Herpes Zoste Drug Report Years Considered
Figure 15. Global Herpes Zoste Drug Sales 2017-2028 (K Pcs)
Figure 16. Global Herpes Zoste Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Herpes Zoste Drug Revenue 2017-2028 (US$ Million)
Figure 18. Global Herpes Zoste Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Herpes Zoste Drug Sales Market Share by Region (2017-2022)
Figure 20. Global Herpes Zoste Drug Sales Market Share by Region (2023-2028)
Figure 21. North America Herpes Zoste Drug Sales YoY (2017-2028) & (K Pcs)
Figure 22. North America Herpes Zoste Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Herpes Zoste Drug Sales YoY (2017-2028) & (K Pcs)
Figure 24. Europe Herpes Zoste Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Herpes Zoste Drug Sales YoY (2017-2028) & (K Pcs)
Figure 26. Asia-Pacific Herpes Zoste Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Herpes Zoste Drug Sales YoY (2017-2028) & (K Pcs)
Figure 28. Latin America Herpes Zoste Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Herpes Zoste Drug Sales YoY (2017-2028) & (K Pcs)
Figure 30. Middle East & Africa Herpes Zoste Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Herpes Zoste Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Herpes Zoste Drug in the World: Market Share by Herpes Zoste Drug Revenue in 2021
Figure 33. Global Herpes Zoste Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Herpes Zoste Drug Sales Market Share by Type (2017-2028)
Figure 35. Global Herpes Zoste Drug Revenue Market Share by Type (2017-2028)
Figure 36. Global Herpes Zoste Drug Sales Market Share by Application (2017-2028)
Figure 37. Global Herpes Zoste Drug Revenue Market Share by Application (2017-2028)
Figure 38. North America Herpes Zoste Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Herpes Zoste Drug Revenue Market Share by Type (2017-2028)
Figure 40. North America Herpes Zoste Drug Sales Market Share by Application (2017-2028)
Figure 41. North America Herpes Zoste Drug Revenue Market Share by Application (2017-2028)
Figure 42. North America Herpes Zoste Drug Sales Share by Country (2017-2028)
Figure 43. North America Herpes Zoste Drug Revenue Share by Country (2017-2028)
Figure 44. U.S. Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Herpes Zoste Drug Sales Market Share by Type (2017-2028)
Figure 47. Europe Herpes Zoste Drug Revenue Market Share by Type (2017-2028)
Figure 48. Europe Herpes Zoste Drug Sales Market Share by Application (2017-2028)
Figure 49. Europe Herpes Zoste Drug Revenue Market Share by Application (2017-2028)
Figure 50. Europe Herpes Zoste Drug Sales Share by Country (2017-2028)
Figure 51. Europe Herpes Zoste Drug Revenue Share by Country (2017-2028)
Figure 52. Germany Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 53. France Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Herpes Zoste Drug Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Herpes Zoste Drug Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Herpes Zoste Drug Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Herpes Zoste Drug Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Herpes Zoste Drug Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Herpes Zoste Drug Revenue Share by Region (2017-2028)
Figure 63. China Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 66. India Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Herpes Zoste Drug Sales Market Share by Type (2017-2028)
Figure 74. Latin America Herpes Zoste Drug Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Herpes Zoste Drug Sales Market Share by Application (2017-2028)
Figure 76. Latin America Herpes Zoste Drug Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Herpes Zoste Drug Sales Share by Country (2017-2028)
Figure 78. Latin America Herpes Zoste Drug Revenue Share by Country (2017-2028)
Figure 79. Mexico Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Herpes Zoste Drug Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Herpes Zoste Drug Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Herpes Zoste Drug Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Herpes Zoste Drug Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Herpes Zoste Drug Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Herpes Zoste Drug Revenue Share by Country (2017-2028)
Figure 88. Turkey Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 90. U.A.E Herpes Zoste Drug Revenue (2017-2028) & (US$ Million)
Figure 91. Herpes Zoste Drug Value Chain
Figure 92. Herpes Zoste Drug Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
Industry Market Size
